Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
29 August 1991Website:
http://www.brooklynitx.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | 110 min agoDividend
Analysts recommendations
Institutional Ownership
What type of business is Eterna Therapeutics?
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
What sector is Eterna Therapeutics in?
Eterna Therapeutics is in the Healthcare sector
What industry is Eterna Therapeutics in?
Eterna Therapeutics is in the Biotechnology industry
What country is Eterna Therapeutics from?
Eterna Therapeutics is headquartered in United States
When did Eterna Therapeutics go public?
Eterna Therapeutics initial public offering (IPO) was on 29 August 1991
What is Eterna Therapeutics website?
https://www.brooklynitx.com
Is Eterna Therapeutics in the S&P 500?
No, Eterna Therapeutics is not included in the S&P 500 index
Is Eterna Therapeutics in the NASDAQ 100?
No, Eterna Therapeutics is not included in the NASDAQ 100 index
Is Eterna Therapeutics in the Dow Jones?
No, Eterna Therapeutics is not included in the Dow Jones index
When does Eterna Therapeutics report earnings?
The next expected earnings date for Eterna Therapeutics is 09 August 2024